Results showed that KDM1A expression implies a poorer prognosis on PFS (HR: 3.47, 95% CI: 1.14–10.57, p = 0.0289) and a worse OS (HR: 7.67, 95% CI: 1.95–1.03, p = 0.0036), while the remaining covariates (age, sex, tumor stage) showed no statistical significance on PFS and OS (all p > 0.05). The gene discussed is KDM1A; the disease is neoplasm.